Topic Review
Antibiotic Susceptibility and Biofilm Formation in Cystic Fibrosis
Patients with cystic fibrosis (CF) are repeatedly exposed to antibiotics, especially during the pulmonary exacerbations of the disease. However, the available therapeutic strategies are frequently inadequate to eradicate the involved pathogens and most importantly, facilitate the development of antimicrobial resistance (AMR). The evaluation of AMR is demanding; conventional culture-based susceptibility-testing techniques cannot account for the lung microenvironment and/or the adaptive mechanisms developed by the pathogens, such as biofilm formation.
  • 317
  • 30 Jan 2023
Topic Review
Antibiotic Susceptibility Testing
Antibiotic susceptibility testing (AST) specifies effective antibiotic dosage and formulates a profile of empirical therapy for the proper management of an individual patient’s health against deadly infections. Therefore, rapid diagnostic plays a pivotal role in the treatment of bacterial infection.
  • 1.5K
  • 03 Jan 2022
Topic Review
Antibiotic Therapy for Active Crohn’s Disease Targeting Pathogens
Crohn’s disease (CD) is a multifactorial chronic disorder that involves a combination of factors, including genetics, immune response, and gut microbiota. Therapy includes salicylates, immunosuppressive agents, corticosteroids, and biologic drugs. 
  • 227
  • 09 Feb 2024
Topic Review
Antibiotic Therapy of Sepsis Stewardship
The main recent change observed in the field of critical patient infection has been the universal awareness of the need to make better use of antimicrobials, especially in the most seriously ill patients, beyond the application of simple formulas and rigid protocols. The greatest challenge, therefore, of decision making in this context lies in determining an effective, optimal, and balanced empirical antibiotic treatment. This is sepsis stewardship.
  • 265
  • 07 Feb 2024
Topic Review
Antibiotic Use and Resistance in Agriculture Sector
Possible new ways for the development of novel classes of antibiotics are discussed here, for which there is no pre-existing resistance in human bacterial pathogens. By utilizing research and technology such as nanotechnology and computational methods (such as in silico and Fragment-based drug design (FBDD)), there has been an improvement in antimicrobial actions and selectivity with target sites. Moreover, there are antibiotic alternatives, such as antimicrobial peptides, essential oils, anti-Quorum sensing agents, darobactins, vitamin B6, bacteriophages, odilorhabdins, 18β-glycyrrhetinic acid, and cannabinoids. Additionally, drug repurposing (such as with ticagrelor, mitomycin C, auranofin, pentamidine, and zidovudine) and synthesis of novel antibacterial agents (including lactones, piperidinol, sugar-based bactericides, isoxazole, carbazole, pyrimidine, and pyrazole derivatives) represent novel approaches to treating infectious diseases. Nonetheless, prodrugs (e.g., siderophores) have shown to be an excellent platform to design a new generation of antimicrobial agents with better efficacy against multidrug-resistant bacteria.
  • 419
  • 03 Apr 2023
Topic Review
Antibiotic-Free Broiler Meat
Chickens are raised with the assistance of the regular use of antibiotics, not only for the prevention and treatment of diseases but, also, for body growth. Overuse and misuse of antibiotics in animals are contributing to the rising threat of antibiotic resistance. This practice contributes to the development of drug-resistant bacteria in livestock, including poultry, and humans through the food chain, posing a global public health threat. Therefore, antibiotic-free broiler meat production is becoming increasingly popular worldwide to meet consumer demand. However, numerous challenges need to be overcome in producing antibiotic-free broiler meat by adopting suitable strategies regarding food safety and chicken welfare issues.
  • 1.1K
  • 15 Dec 2020
Topic Review
Antibiotic-Related Changes in Microbiome
The interplay between drugs and microbiota is critical for successful treatment. An accumulating amount of evidence has identified the significant impact of intestinal microbiota composition on cancer treatment response, particularly immunotherapy. The possible molecular pathways of the interaction between immune checkpoint inhibitors (ICIs) and the microbiome can be used to reverse immunotherapy tolerance in cancer by using various kinds of interventions on the intestinal bacteria. This paper aimed to review the data available on how the antibiotic-related changes in human microbiota during colorectal cancer (CRC) treatment can affect and determine ICI treatment outcomes. We also covered the data that support the potential intimate mechanisms of both local and systemic immune responses induced by changes in the intestinal microbiota. However, further better-powered studies are needed to thoroughly assess the clinical significance of antibiotic-induced alteration of the gut microbiota and its impact on CRC treatment by direct observations of patients receiving antibiotic treatment. 
  • 647
  • 18 Feb 2021
Topic Review
Antibiotics and Steroids on Nasal Microbiomein CRS Patients
The nasal microbiome represents the main environmental factor of the inflammatory process in chronic rhinosinusitis (CRS). Antibiotics and steroids constitute the mainstay of CRS therapies. 
  • 246
  • 23 Nov 2023
Topic Review
Antibiotics in Avian Species
Bacterial infections are commonly diagnosed and treated with antibiotics in the avian species. Infected birds can spread zoonotic diseases such as influenza, psittacosis, pasteurellosis, and campylobacteriosis to humans, especially if they are in close contact with them, such as pet-owner settings, zoos, or pet shops. The elimination of bacterial infections in birds is therefore important for both human and avian health.
  • 1.2K
  • 08 Jun 2022
Topic Review
Antibiotics in Poultry Farming
Antibiotics in poultry farming is the controversial prophylactic use of antibiotics in the poultry farming industry in the USA. This does not represent the position in other countries. Antibiotics have been applied in mass quantities since 1951 in the USA, when its Food and Drug Administration (FDA) approved their use. Three years prior to the FDA's approval, scientists were investigating a phenomenon in which chickens who were rooting through bacteria-rich manure were displaying signs of greater health than those who did not. Through testing, it was discovered that chickens who were fed a variety of vitamin B12 manufactured with the residue of a certain antibiotic grew 50 percent faster than those chickens who were fed B12 manufactured from a different source. Further testing confirmed that use of antibiotics did improve the health of the chickens, resulting in the chickens laying more eggs and experiencing lower mortality rates and less illness. Upon this discovery, farmers transitioned from expensive animal proteins to comparatively inexpensive antibiotics and B12. Chickens were now reaching their market weight at a much faster rate and at a lower cost. With a growing population and greater demand on the farmers, antibiotics appeared to be an ideal and cost-effective way to increase the output of poultry. Since this discovery, antibiotics have been routinely used in poultry production, but more recently have been the topic of debate secondary to the fear of bacterial antibiotic resistance.
  • 818
  • 16 Nov 2022
  • Page
  • of
  • 1352
ScholarVision Creations